bacillus Calmette-Guerin

Also found in: Dictionary, Encyclopedia.
Related to bacillus Calmette-Guerin: Bacillus Calmette-Guerin vaccine, Bacillus Calmette-Guérin

bacillus Cal·mette-Gué·rin

(kăl-mĕt′gā-răn′, käl-mĕt′gā-răN′)
n. Abbr. BCG
An attenuated strain of tubercle bacillus grown in repeated cultures on medium containing bile and used in tuberculosis vaccines. Also called bacille Calmette-Guérin.
References in periodicals archive ?
Intravesical Bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours.
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns.
The value of perioperative mitomycin C instillation in improving subsequent bacillus calmette-guerin instillation efficacy in intermediate and high-risk patients with non-muscle invasive bladder cancer: A prospective randomized study.
The proposed indication (use) for this product is treatment of non-muscle invasive bladder cancer at high risk of recurrence or progression in adult patients who failed prior Bacillus Calmette-Guerin (BCG) immunotherapy, e.
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with nonmuscle invasive bladder cancer and recurrence after 2 prior courses of intravesical bacillus Calmette-Guerin.
Bacillus Calmette-Guerin lymphadenitis: a 6-year experience in two Saudi hospitals.
The current standard of care for non-muscle-invasive bladder cancer (NMIBC) includes chemotherapy within the bladder and Bacillus Calmette-Guerin (BCG) immunotherapy, which are associated with significant side effects.
MCNA was developed to be delivered as a sterile suspension for intravesical administration by urologists and urology nurses, following the same dosing paradigm as first-line bacillus Calmette-Guerin (BCG) therapy, with the advantage that it can be prepared, handled and disposed of easily and safely.
We report a case of CG, which was resistant to transurethral resection, partial cystectomy, intravesical mitomycin, and bacillus Calmette-Guerin (BCG) treatment and can affect the upper urinary tract.
Initial human trials found that Urocidin is effective and much safer than previous treatment options for cases of superficial bladder cancer that is not responsive to Bacillus Calmette-Guerin (BCG) therapy.
Bacillus Calmette-Guerin (BCG) vaccine-induced complications in children treated with highly active antiretroviral therapy.
To the Editor: Disseminated bacillus Calmette-Guerin (BCG) infection has been noted in patients with primary immunodeficiency.
Full browser ?